To hear about similar clinical trials, please enter your email below
Trial Title:
Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
NCT ID:
NCT06645132
Condition:
Blood Cancer
Bone Marrow Transplant (BMT)
Conditions: Official terms:
Hematologic Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
exercise intervention
Description:
Exercise intervention leveraging wearable devices and a custom smartphone application to
cue exercise as a reminder during idle time during an inpatient hospital stay, post
allogenic bone marrow transplant.
Arm group label:
Reminders to exercise through cues provided by wearable device + custom smartphone application
Summary:
The purpose of this study is to pilot test the feasibility of providing patients
diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant,
a wearable device and smartphone app (similar to a Fitbit), that would send personalized
reminders to move during their post-transplant inpatient hospital stay to promote
physical recovery and well-being.
Detailed description:
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled
to undergo an allogeneic bone marrow transplant will use a custom-designed wearable
device and smartphone application as a behavioral intervention to cue exercise.
Participants will be asked to wear the wearable device for the duration of their
post-transplant inpatient hospital stay.
Aim 1. To examine the potential efficacy of the wearable device + smartphone application
to prompt alloBMT patients to move.
Aim 2. To receive participant feedback on their experience participating in the study.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- At least 18 years of age
- Diagnosed with hematologic malignancy
- Scheduled to receive an alloBMT
- Physician consent to participate in the study
Exclusion Criteria:
• Inability to complete 15 minutes walking unassisted
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Froedtert Hospital
Address:
City:
Milwaukee
Zip:
53226
Country:
United States
Contact:
Last name:
Kelly Clohesey Clinical Research Coordinator
Phone:
414-955-4099
Email:
kclohesey@mcw.edu
Start date:
October 2024
Completion date:
September 2025
Lead sponsor:
Agency:
Medical College of Wisconsin
Agency class:
Other
Source:
Medical College of Wisconsin
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06645132
